Fields »
ABOUT
HELP
BLOG

6245 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 125 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
A1CFAPOBEC1 complementation factor
NucleoplasmTissue enhancedduodenum:24.2
liver:75.9
small intestine:30.4
AAGABAlpha- and gamma-adaptin binding protein
Nuclear speckles
Cytosol		Renal cancer: 1.36e-4
Thyroid cancer: 9.48e-4
Expressed in all
AAMDCAdipogenesis associated, Mth938 domain containing
Nucleoplasm
Cytosol		Expressed in all
ABCA1ATP-binding cassette, sub-family A (ABC1), member 1
Nucleoplasm
Vesicles		Mixed
ABCA3ATP-binding cassette, sub-family A (ABC1), member 3
Nucleoplasm
Cytosol		Tissue enhancedlung:135.8
ABCA6ATP-binding cassette, sub-family A (ABC1), member 6
NucleoplasmLiver cancer: 3.29e-4
Tissue enhancedliver:41.4
ABCA8ATP-binding cassette, sub-family A (ABC1), member 8
Nucleoplasm
Cytosol		Mixed
ABCB1ATP-binding cassette, sub-family B (MDR/TAP), member 1
Nucleoplasm
Focal adhesion sites
Cytosol		Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedadrenal gland:138.6
small intestine:83.9
ABCB11ATP-binding cassette, sub-family B (MDR/TAP), member 11
Nucleoplasm
Plasma membrane
Cytosol		Tissue enriched13liver:19.1
ABCB4ATP-binding cassette, sub-family B (MDR/TAP), member 4
Nucleoplasm
Plasma membrane
Actin filaments
Focal adhesion sites		Tissue enriched6liver:69.2
ABCB6ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol		Renal cancer: 1.52e-7
Liver cancer: 9.45e-7
Expressed in all
ABCB8ATP-binding cassette, sub-family B (MDR/TAP), member 8
Nucleus
Mitochondria		Pancreatic cancer: 3.34e-4
Renal cancer: 5.88e-4
Head and neck cancer: 5.91e-4
Expressed in all
ABCC5ATP-binding cassette, sub-family C (CFTR/MRP), member 5
Nucleus
Plasma membrane
Cell Junctions		Liver cancer: 6.78e-8
Prostate cancer: 3.40e-4
Expressed in all
ABCC9ATP-binding cassette, sub-family C (CFTR/MRP), member 9
Nucleoplasm
Cytosol		Renal cancer: 1.85e-5
Mixed
ABCG2ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
Nucleus
Plasma membrane		Tissue enhancedsmall intestine:116.1
ABCG5ATP-binding cassette, sub-family G (WHITE), member 5
NucleusLiver cancer: 2.60e-5
Group enriched32duodenum:58.0
liver:28.3
small intestine:57.4
ABHD12BAbhydrolase domain containing 12BN/A
NucleusTissue enriched6skin:16.3
ABHD14BAbhydrolase domain containing 14B
Nucleus
Nucleoli
Cytosol		Renal cancer: 2.93e-5
Endometrial cancer: 5.42e-5
Cervical cancer: 6.92e-5
Expressed in all
ABHD15Abhydrolase domain containing 15
Nucleoplasm
Cytosol		Mixed
ABHD16BAbhydrolase domain containing 16BN/A
NucleoplasmMixed
ABHD2Abhydrolase domain containing 2
Nucleoplasm
Cytosol		Renal cancer: 2.18e-7
Expressed in all
ABHD3Abhydrolase domain containing 3
Nucleus
Vesicles
Plasma membrane		Melanoma: 8.52e-4
Expressed in all
ABHD4Abhydrolase domain containing 4
NucleusExpressed in all
ABHD6Abhydrolase domain containing 6
Nucleoplasm
Vesicles		Renal cancer: 1.11e-11
Colorectal cancer: 1.13e-4
Mixed
ABHD8Abhydrolase domain containing 8
Nucleoplasm
Nuclear bodies		Pancreatic cancer: 3.04e-5
Colorectal cancer: 5.25e-4
Mixed
ABI2Abl-interactor 2
NucleoplasmExpressed in all
ABI3BPABI family, member 3 (NESH) binding protein
Nucleoli
Nuclear speckles
Centrosome
Cytosol		Renal cancer: 6.14e-4
Mixed
ABL1ABL proto-oncogene 1, non-receptor tyrosine kinase
Nucleoplasm
Nuclear bodies		Expressed in all
ABL2ABL proto-oncogene 2, non-receptor tyrosine kinase
NucleoplasmRenal cancer: 1.78e-7
Cervical cancer: 3.50e-4
Urothelial cancer: 8.40e-4
Mixed
ABLIM2Actin binding LIM protein family, member 2
Nucleoplasm
Mitochondria		Tissue enhancedskeletal muscle:37.7
spleen:28.9
ABLIM3Actin binding LIM protein family, member 3
Nucleoplasm
Plasma membrane
Cell Junctions		Renal cancer: 1.28e-4
Tissue enhancedparathyroid gland:78.1
ABRActive BCR-related
Nucleoplasm
Cytosol		Renal cancer: 2.21e-4
Cervical cancer: 4.03e-4
Mixed
ABRACLABRA C-terminal like
Nucleoplasm
Cytosol		Urothelial cancer: 1.65e-6
Mixed
ABTB2Ankyrin repeat and BTB (POZ) domain containing 2
NucleusRenal cancer: 3.51e-5
Cervical cancer: 5.70e-5
Mixed
AC003006.7
NucleusNot detected
AC004754.3
Nucleoplasm
Mitochondria		Group enriched5duodenum:14.6
small intestine:8.1
AC009950.1N/A
NucleusMixed
AC104057.1
Nucleoplasm
Nuclear bodies		Not detected
AC104073.2
Nucleoplasm
Nuclear bodies		Not detected
AC138969.4
NucleoplasmExpressed in all
AC241377.2
Nucleoplasm
Nuclear bodies		Mixed
AC241585.2
Nucleoplasm
Nuclear bodies		Mixed
AC245100.1
Nucleoplasm
Nuclear bodies		Ovarian cancer: 2.02e-6
Cervical cancer: 4.26e-4
Mixed
ACADSAcyl-CoA dehydrogenase, C-2 to C-3 short chain
Nucleoplasm
Mitochondria		Renal cancer: 3.33e-6
Urothelial cancer: 6.34e-5
Liver cancer: 2.43e-4
Endometrial cancer: 5.05e-4
Glioma: 9.94e-4
Expressed in all
ACADVLAcyl-CoA dehydrogenase, very long chain
Nucleus
Nucleoli
Mitochondria		Pancreatic cancer: 6.87e-4
Expressed in all
ACAP3ArfGAP with coiled-coil, ankyrin repeat and PH domains 3
Nucleoplasm
Golgi apparatus		Expressed in all
ACAT2Acetyl-CoA acetyltransferase 2
Nucleus
Cytosol		Colorectal cancer: 1.12e-4
Endometrial cancer: 7.25e-4
Renal cancer: 7.38e-4
Mixed
ACBD4Acyl-CoA binding domain containing 4
Nucleus
Vesicles		Pancreatic cancer: 4.64e-4
Liver cancer: 4.76e-4
Urothelial cancer: 6.53e-4
Expressed in all
ACBD6Acyl-CoA binding domain containing 6
Nucleoplasm
Cytosol		Renal cancer: 4.02e-7
Expressed in all
ACDAdrenocortical dysplasia homolog (mouse)
Nuclear bodiesLiver cancer: 2.42e-6
Mixed

Page of 125 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.